Novotech Signs MOU with China Medical University Hospital in Taiwan


Applied Clinical Trials

Asia-Pacific specialist CRO Novotech announced that it has signed a Memorandum of Understanding with the China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials.

Read the full release here.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.